X0206 3/A 2016-04-06 2016-04-18 0 0001068874 IMPLANT SCIENCES CORP IMSC 0001299265 Platinum Partners Value Arbitrage Fund, LP 250 WEST 55TH STREET 14TH FLOOR NEW YORK NY 10019 true Not subject to reporting 0001368616 Platinum Management (NY) LLC 250 WEST 55TH STREET NEW YORK NY 10019 true Not subject to reporting 0001672345 DMRJ GROUP LLC 250 WEST 55TH STREET, 14TH FLOOR NEW YORK NY 10019 true Not subject to reporting 0001672474 MONTSANT PARTNERS, LLC 250 WEST 55TH STREET, 14TH FLOOR NEW YORK NY 10019 true Not subject to reporting 0001339643 Nordlicht Mark 250 WEST 55TH STREET NEW YORK NY 10019 true Not subject to reporting Common Stock par value $0.10 2081829 I By MONTSANT PARTNERS, LLC March 2009 Note Series J Preferred Stock I By MONTSANT PARTNERS, LLC March 2009 Note Common Stock, par value $0.10 I By MONTSANT PARTNERS, LLC September 2012 Note Series H Preferred Stock I By DMRJ GROUP LLC September 2012 Note Common Stock, par value $0.10 I By DMRJ GROUP LLC February 2013 Note Series I Preferred Stock I By DMRJ GROUP LLC February 2013 Note Common Stock, par value $0.10 I By DMRJ GROUP LLC This amendment is being filed to correct erroneous statements in the Form 3 filed on April 18, 2016 (the "Original Form 3") indicating that the Reporting Persons had certain reportable beneficial ownership of the securities and underlying securities noted above. The Reporting Persons do not and have not beneficially owned 10% or more of any class of equity securities of Implant Sciences Corp registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, and, accordingly, are not and have not been Section 16 Reporting Persons with respect to the Issuer. Accordingly, none of the Reporting Persons currently have or have had at any time from (and including) the date of the event reported on the Original Form 3, any obligation to report beneficial ownership on this Form, and the Form has been amended to so reflect. /s/ Joseph SanFilippo, Attorney-in-Fact 2016-07-19